Provided by Tiger Fintech (Singapore) Pte. Ltd.

AdaptHealth Corp.

8.50
-0.0100-0.12%
Post-market: 8.500.00000.00%16:01 EDT
Volume:2.12M
Turnover:18.02M
Market Cap:1.15B
PE:13.93
High:8.67
Open:8.52
Low:8.32
Close:8.51
Loading ...

AdaptHealth Corp. (AHCO) Q4 Earnings and Revenues Surpass Estimates

Zacks
·
25 Feb

AdaptHealth Swings to Profit in Q4, Revenue Declines; Shares Gain Pre-Bell

MT Newswires Live
·
25 Feb

Adapthealth Shares up 8.2% Premarket After Q4 Revenue Beats Estimates

THOMSON REUTERS
·
25 Feb

Stock Track | AdaptHealth Corp. Soars 8.19% in Pre-Market on Strong Q4 Earnings Beat

Stock Track
·
25 Feb

GUIDANCE: (AHCO) AdaptHealth Expects Fiscal 2025 Net Revenue Range $3.22B - $3.36B, vs. FactSet Est of $3.33B

MT Newswires Live
·
25 Feb

Earnings Flash (AHCO) AdaptHealth Posts Q4 EPS $0.34, vs. FactSet Est of $0.25

MT Newswires Live
·
25 Feb

AdaptHealth Q4 Sales $856.65M Beat $829.19M Estimate

Benzinga
·
25 Feb

BRIEF-Adapthealth Q4 Revenue USD 856.645 Million Vs. IBES Estimate USD 829.2 Million

Reuters
·
25 Feb

Adapthealth Q4 Revenue USD 856.645 Million VS. Ibes Estimate USD 829.2 Million

THOMSON REUTERS
·
25 Feb

Adapthealth Q4 Net Income USD 51.403 Million VS. Ibes Estimate USD 34.1 Million

THOMSON REUTERS
·
25 Feb

Adapthealth Q4 Pretax Profit USD 70.711 Million VS. Ibes Estimate USD 50 Million

THOMSON REUTERS
·
25 Feb

AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2024 Results and Provides 2025 Outlook

Business Wire
·
25 Feb

AdaptHealth Earnings: What To Look For From AHCO

StockStory
·
24 Feb

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
21 Feb

Down -16.54% in 4 Weeks, Here's Why AdaptHealth (AHCO) Looks Ripe for a Turnaround

Zacks
·
17 Feb

Senior Health, Home Health & Hospice Stocks Q3 Results: Benchmarking Brookdale (NYSE:BKD)

StockStory
·
14 Feb

AHCO or ABT: Which Is the Better Value Stock Right Now?

Zacks
·
14 Feb

AdaptHealth Is Maintained at Buy by UBS

Dow Jones
·
13 Feb

Should Value Investors Buy AdaptHealth (AHCO) Stock?

Zacks
·
13 Feb

UBS Adjusts Price Target on AdaptHealth to $11 From $12, Keeps Buy Rating

MT Newswires Live
·
13 Feb